Mecobalamin (CAS NO. 13422-55-4), chemically known as α-(5,6-dimethylbenzimidazolyl)-Co-methylcobamide or Methylcobalamin, is one of the two active coenzyme forms of Vitamin B12 utilized by human metabolism. Unlike synthetic Cyanocobalamin which requires multi-step enzymatic cleavage and reduction within the liver to achieve metabolic utility, Mecobalamin possesses an active methyl group attached directly to the cobalt atom in a corrin ring coordination complex. This specific molecular structure enables direct participation in transmethylation cycles, methionine synthesis from homocysteine, and the synthesis of myelin sheaths surrounding peripheral nerve axons.
For global pharmaceutical procurement officers, drug developers, and contract manufacturing organizations (CMOs), sourcing high-grade Mecobalamin API requires rigorous technical assessment of chemical purity, crystal morphology, photolytic stability, and heavy metal profiles. Given its vital role in neurology, ophthalmology, and hematology, international regulatory authorities (USP, EP, JP, and ChP) impose strict monographic criteria to ensure drug efficacy and patient safety.
| Parameter | Specification Limit | Analytical Method | Significance for Formulators |
|---|---|---|---|
| Chemical Identity | Positive IR spectrum & UV/Vis spectrum alignment | FTIR / UV-Vis Spectroscopy | Confirms structural integrity of corrin ring system |
| HPLC Assay (Dry Basis) | 98.0% – 102.0% w/w | High-Performance Liquid Chromatography | Guarantees active dosing uniformity in oral & injectable finished dosage forms (FDF) |
| Hydroxocobalamin Impurity | ≤ 1.0% | Reverse-Phase HPLC | Controls photolytic degradation byproduct levels |
| Loss on Drying | ≤ 11.5% | Gravimetric / Vacuum Drying | Prevents moisture-induced crystal transition and degradation |
| Heavy Metals (Pb, As, Cd, Hg) | ≤ 10 ppm combined | ICP-MS (Inductively Coupled Plasma) | Ensures full elemental impurity compliance (ICH Q3D) |
| Bacterial Endotoxins | < 0.25 EU/mg (Injectable Grade) | LAL Kinetic Chromogenic Test | Essential for parenteral solution & nerve-block injection safety |
China has established itself as the world's primary production hub for cobalamin derivatives, including Mecobalamin, Cyanocobalamin, and Adenosylcobalamin. Driven by advanced fermentation technologies, comprehensive upstream chemical integration, and modern cGMP manufacturing facilities, Chinese suppliers offer significant technological and economic benefits to global pharmaceutical enterprises.
Chinese factories utilize high-yielding strains of Pseudomonas denitrificans and Propionibacterium shermanii. Through precise carbon-source management and automated bio-reactor controls, fermentation yields exceed industry averages, dramatically lowering raw material costs for the cobalamin precursor matrix.
Converting Cyanocobalamin or Hydroxocobalamin to methylcobalamin requires delicate cobalt-methylation. Leading Chinese factories employ eco-friendly, high-selectivity methylating agents (such as dimethyl sulfate alternative green catalysts) yielding reduced photolytic degradation and fewer related substances.
With specialized industrial parks covering over 250,000 square meters, Chinese manufacturers maintain massive buffer stocks and multi-ton annual outputs. This guarantees continuous supply chain resilience, protecting global buyers against geopolitical and raw material volatility.
Modern Chinese pharmaceutical factories operate under strict National Environmental Protection Standards. Integrated zero-liquid-discharge (ZLD) effluent treatment systems, advanced volatile organic compound (VOC) thermal oxidizers, and carbon footprint reduction initiatives ensure long-term regulatory sustainability and uninterrupted production schedules.
The traditional synthesis of Mecobalamin faced major hurdles regarding photolytic degradation—Mecobalamin's cobalt-methyl bond is extremely sensitive to ambient light, particularly in the 300–500 nm range. Recent technological breakthroughs by leading manufacturers have revolutionized handling and production:
By transitioning from batch crystallization to microfluidic continuous-flow synthesis under yellow-monochromatic safe light (wavelength > 600 nm), manufacturers prevent degradation during the delicate isolation step. This leads to crystal structures with superior flowability and lower residual solvent profiles.
Direct compression (DC) tablet formulation demands precise particle size distribution. Modern micronization techniques allow manufacturers to deliver customized d90 distributions ranging from 10 microns (for rapid sublingual dissolution) to 150 microns (for sustained-release oral matrices).
Mecobalamin serves across diverse clinical and therapeutic categories. Global enterprise procurement teams must tailor raw material specifications depending on final formulation requirements:
High-dose oral formulations (500μg to 1500μg daily) and ultra-high-dose injectable protocols (up to 50mg for Amyotrophic Lateral Sclerosis clinical therapies) require low-endotoxin, high-solubility sterile grade API.
Mecobalamin eye drops are widely prescribed to alleviate ciliary muscle fatigue and dry eye syndrome. Raw materials must satisfy strict bioburden limits and complete absence of insoluble particulate matter.
Sublingual tablets, oral sprays, and vitamin B-complex synergies utilize spray-dried or trituration grades (e.g., 1% or 10% Mecobalamin diluted with mannitol or dicalcium phosphate) to ensure blending uniformity.
Enterprise buyers evaluating Mecobalamin factories should execute quality audits based on the following essential criteria:
Gentolex’s goal is to create opportunities connecting the world with better services and guaranteed products. Up to date, Gentolex Group has been serving customers from more than 10 countries, specially, representatives are established in Mexico and South Africa. Our main services focus on supplying peptides APIs and Custom Peptides, FDF license out, Technical Support & Consultation, Product Line and Lab Setup, Sourcing & Supply Chain Solutions.
Our main services focus on supplying peptides APIs and Custom Peptides, FDF license out, Technical Support & Consultation, Product Line and Lab Setup, Sourcing & Supply Chain Solutions. An overall factory construction area of 250,000 square meters under international standard to offer flexible, scalable and cost-effective solutions.
Gentolex offers an extensive range of APIs and intermediates for development study and commercial application with cGMP standard from long-term collaborations. Documents and Certificates are supported to customers worldwide.
For those clients who prefer to avoid the complexity of dealing with multiple points of contact, we provide extra customized procurement services with the most superior and comprehensive supply chain sources.
Selank Acetate API is a synthetic heptapeptide active pharmaceutical ingredient composed of TKPRPGP. Developed through neuropharmacological research...
As a professional Thymosin Beta-4 API manufacturer, we provide high-quality Tβ4 peptide API solutions for biotechnology and research organizations...
BPC-157 API is a synthetic pentadecapeptide that has gained increasing attention in peptide research due to its tissue repair properties...
With continuous developments in neuroscience, Semax synthetic peptide derived from ACTH fragment has attracted wide scientific interest...
SS-31 API (Elamipretide, MTP-131) is a synthetic mitochondria-targeting tetrapeptide designed to bind cardiolipin in the inner mitochondrial membrane...
